Synthetic approaches to the 1,2,5-benzothiadiazepine 1,1-dioxides, sulfonamide analogues of the 1,4-benzodiazepines, are reviewed. The review incorporates the synthesis of bicyclic, tricyclic and tetracyclic systems, and includes approaches to sulfonamide analogues of the antitumour pyrrolobenzodiazepines, sulfonamide analogues of the tricyclic non-nucleosidic reverse transcriptase inhibiting benzodiazepines (such as nevirapine), and other systems of biological interest. Details of the reactions and biological activity of the 1,2,5-benzothiadiazepines are also given.
TsuchiyaT., in Comprehensive Heterocyclic Chemistry II – A Review of The Literature 1982–1995; KatritzkyA.R., ReesC. W., and ScrivenE. F. V. (Eds.); Pergamon: New York, 1996; Vol. 9: Seven-membered & larger rings & fused derivatives; G.R. Newkome (Vol. Ed.); Chapter 9.15: Seven-membered rings with three-heteroatoms 1,2,5; pp. 344.
2.
HemmingK., in Second Supplements to the 2nd Edition of Rodd's Chemistry of Carbon Compounds; SainsburyM. (Ed.); Elsevier Science: Amsterdam, 1999; Vol. IVK, Chap. 52: Compounds with larger heterocyclic rings: seven-membered ring compounds with two or more different elements in the ring, pp. 288.
3.
SharpJ.T., in Comprehensive Heterocyclic Chemistry; KatritzkyA.R., and ReesC. W. (Eds.); Pergamon: New York, 1984; Vol. 7: Small & Large Rings; W. Lwowski, (Vol. Ed.); Chapter 5.18: Seven-membered rings with two or more heteroatoms, pp. 644.
4.
(a) MigliaraO., PetrusoS., and SpiroV., J. Heterocycl. Chem., 1979, 16, 835.
5.
WeiP.H. L., and BellS. C., US patent 3453266 (1969); Chemical Abstracts, 71: 91553.
6.
StarkeI., DahlstromM. U. J., BlombergD., AlenfalkS., SkjaretT., and LemurellM., World patent WO 2003022286 (2003); Chem. Abs., 138: 238208.
7.
OgawaK., and MatsushitaY., Chem. Pharm. Bull., 1992, 40, 2442.
8.
LeftherisK., HuntJ. T., and DingC. Z., US patent 6156746 (2000); Chem. Abs., 134: 29439.
9.
CherneyR.J., DuanJ. J.-W, VossM. E., ChenL., WangL., MeyerD. T., WassermanZ. R., HardmanK. D., LiuR.-Q, CovingtonM. B., QianM., MandlekarS., ChristD. D., TrzaskosJ. M., MagoldaR. L., WexlerR. R., and DeciccoC. P., J. Med. Chem., 2003, 46, 1811.
10.
KrülleT.M., and WijkmansJ. C. H. M., Tetrahedron, 2001, 57, 7021.
11.
(a) BorsiniF., VolterraG., LecciA., EvangelistaS., MancinelliA., CutrufoC., ParliniM., MenniniT., BaroneD., and MeliA., Arzneim. Forsch. Drug Res., 1991, 41-1, 573–580.
12.
GiannottiD., VitiG., SbraciP., PestelliniV., VolterraG., BorsiniF., MeliA., DapportoP., and PaoliP., J. Med. Chem., 1991, 34, 1356
13.
(a) BellarosaD., AntonelliG., BambacioniF., GiannottiD., VitiG., NanniciniR., GiachettiA., DianzaniF., WitvrouwM., PauwelsR., DesmyterJ., and De ClercqE., Antiviral Res., 1996, 30, 109.
Di SantoR., CostiR., ArticoM., MassaS., MarongiuM. E., LoiA. G., De MontisA., and La CollaP., Antiviral Chem. Chemother., 1998, 9, 127.
16.
ArticoM., SilvestriR., PagnozziE., StefancichG., MassaS., LoiA. G., PutzoluM., CorriasS., SpigaM. G., and La CollaP., Bioorg. Med. Chem., 1996, 4, 837.
17.
SilvestriR., ArticoM., PagnozziE., StefancichG., MassaS., La CollaP., LoiA. G., SpigaM. G., CorriasS., and LichinoD., Farmaco, 1996, 51, 425.
18.
(a) AdamsJ., and MerluzziV. J., in The Search For Antiviral Drugs-Case Histories From Concept To Clinic; AdamsJ., and MerluzziV. J. (Eds.); Birkhäuser: Boston, 1993; Chapter 3: Discovery of nevirapine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, pp. 45. (b) V.J. Merluzzi, K.D. Hargrave, M. Labadia, K. Grozinger, M. Skoog, J.C. Wu, C.-K. Shih, K. Eckner, S. Hattox, J. Adams, A.S. Rosenthal, R. Faanes, R.J. Eckner, R.A. Koup and J.L. Sullivan, Science, 1990, 250, 1411.
19.
CostiR., Di SantoR., ArticoM., and MassaS., J. Heterocycl. Chem., 2002, 39, 81.
